Immutep is a biotechnology firm that develops immunotherapy treatments for cancer and autoimmune conditions using its proprietary LAG-3 protein technology. The company's lead product is currently in several mid-to-late-stage clinical trials to treat lung, head, and neck cancers. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?
